The New York Times Magazine: More Teens Are Taking Antidepressants. It Could Disrupt Their Sex Lives for Years.
“More Teens Are Taking Antidepressants. It Could Disrupt Their Sex Lives For Years.” By Daniel Berger exposes the ongoing scandal of Post-SSRI Sexual Dysfunction (PSSD) and highlights the question of why there are no deep studies looking into this problem. Many young patients are reporting diminished libido, muted orgasms, genital numbness and emotional blunting that persist well beyond the last dose. The article argues that this isn’t just a “side-effect” to gloss over but may fundamentally interfere with developing sexual selves, intimate relationships and one’s sense of embodiment at a formative age. What makes the story particularly compelling (and alarming) is the sense that this is happening partly in the shadows of medical consent and oversight. The piece calls for a more transparent, informed dialogue around antidepressants in youth—one that treats sexuality not as an afterthought but as a vital part of wellbeing.

